VEGFA and proliferative diabetic retinopathy: Prior research has documented alterations in vascular density (VD) within the macular and optic disc areas following administration of anti-vascular endothelial growth factor (anti-VEGF) or panretinal photocoagulation (PRP) therapy in patients with proliferative diabetic retinopathy (PDR).